Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TUFM | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | ZNF491 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | ENPP3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | HIST2H2AB | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | APH1A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | GAGE12C | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | ASH2L | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | FAM98A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | DAP3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | C21orf59 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |